leisure time -WSS

leisure time

author：leisure time 2025-09-07 00:14:47 - browse：693

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： NVIDIA and Google execs on the future of AI and drug discovery

hotspot

WSS

Anxious about a speech? A startup wants you to pop a minty cardiac drug

What to expect at HLTH 2023, the health care industry conference

Why age limits for politicians are a terrible idea

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

FDA panel signals lack of confidence in Amgen cancer drug data

With measles on the rise, a personal story of a devastating disease

Wikipedia

leisure time

leisure time

Apple is now the first public company to be valued at $3 trillion

Second House panel advances two

Trump demands the U.S. pay no more for drugs than other countries … again

Chemotherapy drug shortage eases slightly but still widespread

Anesthesiologist group: stop taking Ozempic before surgery

Data integrity in scientific journals requires "effort" by publishers, institutions

At least 13 dead in Texas as scorching temps continue

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

The cancer drug shortage isn’t new — and neither are the solutions

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

leisure time

Sana to lay off nearly a third of staff, de

Chan Zuckerberg Biohub Chicago to focus on inflammation

Arc Institute generative AI designs new CRISPR systems

With measles on the rise, a personal story of a devastating disease

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Military medical care influenced by rank and race, new study finds

explore

hotspot

explore

leisure time